Research Article

Indications and Relative Utility of Lower Endoscopy in the Management of Clostridium difficile Infection

Table 1

Patients demographics, comorbidities, risk factors, and clinical presentation.

All patients ( )Recurrent disease ( )Primary disease ( )

Sex, M/F20/236/1014/13
Age, mean, y596258
Length of stay, d121411

Comorbidities
 Cardiac disease28 (65%)12 (75%)16 (59%)
 Immunosuppression24 (56%)11 (69%)13 (48%)
  Steroids21 (49%)11 (69%)10 (37%)
  Cancer13 (30%)7 (44%)6 (22%)
  Transplant12 (28%)6 (38%)6 (22%)
 Pulmonary disease17 (40%)6 (38%)11 (41%)
 Diabetes11 (26%)7 (44%)4 (15%)
 Chronic renal failure11 (26%)5 (31%)6 (22%)

Risk factors
 Antibiotic exposure39 (91%)13 (81%)26 (96%)
 Current/recent hosp.36 (84%)16 (100%)20 (74%)
 Age >6517 (40%)6 (38%)11 (41%)
 Recent surgery15 (35%)3 (19%)12 (44%)

Presentation
 Community*36 (84%)15 (94%)21 (78%)
 Hospital*7 (16%)1 (6%)6 (22%)
 Ileus, distended abdomen 1 (2%)1 (6%)
 Diarrhea42 (98%)15 (94%)27 (100%)
 Presence of fever18 (42%)4 (25%)14 (52%)
 Septic shock7 (16%)3 (19%)4 (15%)
 ICU admission8 (19%)3 (19%)5 (19%)
 WBC >11.0 or <4.029 (67%)10 (63%)19 (70%)
 Albumin <3.220 (47%) 9 (56%)11 (41%)

*Onset of CDI: in the community, or in the hospital while inpatient.